Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
10m agoEnduro Metals Announces $5 Million LIFE Offering
10m agoAdelayde Exploration Commences Work Program on the Sisson North Tungsten Project Directly Bordering Northcliff Resources
10m agoEmperor Metals Hit Visible Gold Again at Duquesne West Gold Project
10m agoOrvana Minerals Reports Q2 FY2026 Exploration Results in Spain
1h agoBLINDED ASSESSMENT OF ACTION3 STATISTICAL ASSUMPTIONS COMPLETE
Theriva Biologics, Inc. logo

Theriva Biologics, Inc.

About

Theriva Biologics, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 17 2026
Theriva™ Biologics Announces Upcoming Presentation of Additional Data from the VIRAGE Phase 2b Clinical Trial of VCN-01 in Metastatic Pancreatic Cancer at AACR 2026 Annual Meeting
Mar 23 2026
Theriva™ Biologics Announces Positive End-of-Phase 2 Meeting with U.S. FDA Regarding the Design of a Phase 3 Trial of VCN-01 in Metastatic Pancreatic Ductal Adenocarcinoma
Mar 12 2026
Theriva™ Biologics Reports Full-Year 2025 Operational Highlights and Financial Results
Feb 18 2026
Theriva™ Biologics Licenses SYN-020 to Rasayana Therapeutics for Multiple Indications
Feb 3 2026
Theriva™ Biologics Announces Upcoming Presentation of Data from VCN-01 Retinoblastoma Phase 1 Clinical Trial at APAO 2026

Community Chat

Ask AI

6ix6ixAIEvents